 You may remain on the study for as long as you are not experiencing intolerable side effects and the disease has not gotten worse. In that case, you will be taken off study. The total length of the study is five 5 years. At the end of the study, if you are still on active treatment, you and your doctor may or may not decide to continue treatment off-study. 